Narcolepsy Medication Linked to Sleep-Related Eating
A new case report highlights potential risks for pediatric patients taking sodium oxybate for narcolepsy.
Updated on Oct. 7, 2026 in Sleep Disorders
Live Poll
Do you trust pharmaceutical labels to disclose all potential side effects of a prescribed medication?
A 15-year-old girl with narcolepsy experienced sleep-related eating disorder after increasing her sodium oxybate dosage to 8 grams per night. The condition, which causes patients to eat while asleep without memory of the event, was resolved after medical intervention.
Why it matters
Sodium oxybate is a common treatment for cataplexy and daytime sleepiness in patients aged 7 and older, but dosage adjustments can trigger parasomnias. This case underscores the importance of monitoring pediatric patients for sleep-related behavioral changes when medication is altered.
A case report published in October 2026 detailed a 15-year-old patient who developed sleep-related eating disorder at an 8-gram nightly dose. This follows a 2022 analysis of a global safety database identifying 185 similar instances of sleep eating linked to the medication.
The players
Journal of Taibah University Medical Sciences
A peer-reviewed medical publication that recently featured a case study on pediatric narcolepsy treatment outcomes.
The details
The patient began consuming large quantities of calorie-dense food during episodes of sleep-related eating disorder one to two hours after her first nightly dose. Medical professionals successfully managed the symptoms by reducing the sodium oxybate dose to 7 grams per night and implementing behavioral safety measures, such as modifying dietary access and bedside snacks. Sodium oxybate is approved to treat cataplexy and excessive daytime sleepiness in children aged 7 and older.
Timeline
December 2021 marked the end of data collection for the global safety database analysis.
The analysis regarding sodium oxybate-associated sleep-related eating was published in 2022.
A new case report regarding a 15-year-old patient was published in October 2026.
Health Landscape
This case sits within a body of research monitoring parasomnias in pediatric patients using central nervous system depressants. It highlights a documented trend of sleep-related eating disorders occurring alongside more commonly recognized sleepwalking symptoms in clinical trials.
If you or your child are taking sodium oxybate, be alert for signs of nighttime eating or memory gaps regarding overnight behavior. These incidents are worth discussing with your doctor to determine if a dosage adjustment or additional safety precautions are necessary.
The takeaway
While sodium oxybate is an effective therapy, it carries a risk of complex sleep behaviors that require active observation by caregivers. If you notice unusual sleep behaviors, consult your physician to review current dosages and safety protocols.
Further reading
For more on managing common conditions and treatments, visit the Sleep Disorders section.
Source note: This article includes information reported by Medical Daily.
Live Poll
Do you trust pharmaceutical labels to disclose all potential side effects of a prescribed medication?
